The Board of Directors, comprised of leading asthma experts, is GINA’s main governing body. It encourages dissemination and adoption of the reports on asthma management through utilization of existing health care structures in individual countries and promotes international collaboration on asthma research.
The GINA Board of Directors meets several times a year to discuss and plan programs and activities to carry out the goals of the GINA program.
Louis-Philippe Boulet MD, chair
Laval University and Quebec Heart and Lung Institute
2725 Chemin Sainte-Foy
Sainte-Foy (Quebec) G1V 4G5 Canada
Eric D. Bateman, MD
University Cape Town Lung Institute
Cape Town, South Africa
Guy Brusselle, MD, PhD, FERS
Department of Respiratory Medicine
Ghent University Hospital
Alvaro A. Cruz, MD
Federal University of Bahia
School of Medicine
Av. Sta. Luzia, 379 ap. 1501 - OB
40295-050 Salvador - BA, Brazil
Mark FitzGerald, MD, treasurer
Vancouver General Hospital
2775 Laurel Street, 7th Floor
Vancouver, BC V5Z 1M9 Canada
Hiromasa Inoue, MD
Department of Pulmonary Medicine Kagoshima University
Kagoshima 890-8520, Japan
Jerry A. Krishnan, MD, PhD
Division of Pulmonary, Critical Care, Sleep, and Allergy
University of Illinois Hospital and Health Sciences System
Chicago, Illinois 60612
Mark L. Levy, MD
Helen K. Reddel, MBBS, PhD
Woolcock Institute of Medical Research
PO Box M77 Missenden Road
Camperdown, NSW 2050, Australia
Arzu Yorgancioglu, MD
Celal Bayar University
Department of Pulmonology
Page last updated: April 2021
GINA Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions:
- Personal Benefits (Consultancy-Lecture Fees) refers to fees for lectures, advisory committees or consultancy services either intermittent or regular, from which a GINA member benefits personally. This includes ongoing attendance at advisory board meetings but would not normally include a situation where an individual is paid for a specific item or for attending or speaking at an occasional meeting.
- Shares refers to any shares in the pharmaceutical industry, excluding unit trusts, pension plans or mutual funds, and it refers to shares held by a GINA member or family members (spouse/children). The company is to be listed, not the number of shares.
- Non-Personal Interests refers to fees or grants paid to a GINA Committee member (or the Department/Institution on behalf of a GINA member) and used for research, education, equipment, salaries, etc.